Family Cancer Center

Memphis, Tennessee 38120

0 studies enrolling now · 3 studies all time

What they study most

Acute Myeloid Leukemia, Melanoma, Metastases, Non Small Cell Lung Cancer

Studies at this site

• Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory AML — Completed
• Trial of Poor Performance Status Patients (ToPPS) — Completed
• MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma — Completed